Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 10, 2012, Pages 5134-5141

  Khan, Saira ^a   Tøndervik, Anne ^b   Sletta, Håvard ^b   Klinkenberg, Geir ^b   Emanuel, Charlotte ^a   Onsøyen, Edvar ^c   Myrvold, Rolf ^c   Howe, Robin A ^d   Walsh, Timothy R ^e   Hill, Katja E ^a   Thomas, David W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SINTEF MATERIALS AND CHEMISTRY   (Norway)

^c ALGIPHARMA AS   (Norway)

^d Velindre NHS Trust   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BETA LACTAM; MACROLIDE; OLIGOSACCHARIDE; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER LWOFFII; ANTIBIOTIC THERAPY; ARTICLE; BIOFILM; BIOMASS; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CONTAMINANS; BURKHOLDERIA DOLOSA; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; DRUG EFFICACY; DRUG POTENTIATION; ESCHERICHIA COLI; INTERCELLULAR SPACE; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS ORALIS;

ACINETOBACTER; ALGINATES; ANTI-BACTERIAL AGENTS; BURKHOLDERIA; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; GENOTYPE; GLUCURONIC ACID; HEXURONIC ACIDS; MICROBIAL SENSITIVITY TESTS; OLIGOSACCHARIDES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS ORALIS;

EID: 84866342560     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00525-12     Document Type: Article

References (35)

1. Ammons MCB, Ward LS, Fishera ST, Wolcott RD, James GA. 2009. In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int. J. Antimicrob. Agents 33:230-236.
2. Aziz MA, Cabral JD, Brooks HJL, Moratti SC, Hanton LR. 2012. Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use. Antimicrob. Agents Chemother. 56:280-287.
3. Campa C, et al. 2004. Biochemical analysis of the processive mechanism for epimerization of alginate by mannuronan C-5 epimerase AlgE4. Biochem. J. 381:155-164. (Pubitemid 38937048)
4. Cardoso K, et al. 2010. DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii. J. Med. Microbiol. 59:1061-1068.
5. Delcour AH. 2009. Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta 1794:808-816.
6. Dutta NK, Mazumdar K, Park JH. 2009. In vitro synergistic effect of gentamicin with the anti-inflammatory agent diclofenac against Listeria monocytogenes. Lett. Appl. Microbiol. 48:783-785.
7. Eckert R, et al. 2006. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob. Agents Chemother. 50:3833-3838. (Pubitemid 44684900)
8. Estrela AB, Heck MG, Abraham W-R. 2009. Novel approaches to control biofilm infections. Curr. Med. Chem. 16:1512-1530.
9. European Committee on Antimicrobial Susceptibility Testing. 2011. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, January 5, 2011. EUCAST, Växjö, Sweden. http://www.eucast.org/ fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/EUCAST-breakpoints-v1. 3-pdf.pdf.
10. Evans K, et al. 1998. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 180:5443-5447. (Pubitemid 28471543)
11. Gimmestad M, et al. 2003. The Pseudomonas fluorescens AlgG protein, but not its mannuronan c-5-epimerase activity, is needed for alginate polymer formation. J. Bacteriol. 185:3515-3523. (Pubitemid 36676417)
12. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108. (Pubitemid 39490064)
13. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell. Microbiol. 11:1034-1043.
14. Hancock REW, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. (Pubitemid 44967479)
15. Ho J, Tambyah PA, Paterson DL. 2010. Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23:546-553.
16. Huber F, Lang HP, Gerber C. 2008. Biosensors: new leverage against superbugs. Nat. Nanotech. 3:645-646.
17. Hurdle JG, O'Neill AJ, Chopra I, Lee RE. 2011. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9:62-75.
18. 8 cfu/ml for in vivo test. Biomed. Pharmacother. 60:220-226.
19. Jorgensen JH, Turnidge JD, Washington JA. 1999. Antibacterial susceptibility tests: dilution and disk diffusion methods, p 1526-1543. In Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (ed), Manual of clinical microbiology, 7th ed. ASM Press, Washington, DC.
20. Klausen M, et al. 2003. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 48:1511-1524. (Pubitemid 36751058)
21. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
22. Lambert PA. 2005. Bacterial resistance to antibiotics: modified target sites. Adv. Drug Deliv. Rev. 57:1471-1485. (Pubitemid 40984602)
23. Lamppa JW, Ackerman ME, Lai JI, Scanlon TC, Griswold KE. 2001. Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity. PLoS One 6:e17042. doi:10.1371/journal. pone.0017042.
24. Lattner D, Flemming HC, Mayer C. 2003. C-13-NMR study of the interaction of bacterial alginate with bivalent cations. Int. J. Biol. Macromol. 3:81-88. (Pubitemid 37346360)
25. Mah TF, et al. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310.
26. Maragakis LL, Perencevich EN, Cosgrove SE. 2008. Clinical and economic burden of antimicrobial resistance. Expert Rev. Anti Infect. Ther. 6:751-763.
27. Mark BL, Vocadlo DJ, Oliver A. 2011. Providing beta-lactams a helping hand: targeting the AmpC beta-lactamase induction pathway. Future Microbiol. 6:1415-1427.
28. Nehme D, Poole K. 2007. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors. J. Bacteriol. 189:6118-6127. (Pubitemid 47378618)
29. Overhage J, Lewenza S, Marr AK, Hancock REW. 2007. Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 Mini-Tn5-lux mutant library. J. Bacteriol. 189:2164-2169. (Pubitemid 46446186)
30. Rehm BHA. 2010. Bacterial polymers: biosynthesis, modifications and applications. Nat. Rev. Microbiol. 8:578-592.
31. Schürks N, Wingender J, Flemming HC, Mayer C. 2002. Monomer composition and sequence of alginates from Pseudomonas aeruginosa. Int. J. Biol. Macromol. 30:105-111. (Pubitemid 34242689)
32. Shi XW, et al. 2005. Ionically crosslinked alginate/carboxymethyl chitin beads for oral delivery of protein drugs. Macromol. Biosci. 5:881-889.
33. Silverman JA, Mortin LI, VanPraagh ADG, LI TC, Alder J. 2005. Inhibition of daptomycin by pulmonary surfactant: in vitro modelling and clinical impact. J. Infect. Dis. 191:2149-2152. (Pubitemid 40800587)
34. Wigle TJ, et al. 2009. Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J. Biomol. Screen. 14:1092-1101.
35. Yan GL, Guo YM, Yuan JM, Liu D, Zhang BK. 2011. Sodium alginate oligosaccharides from brown algae inhibit Salmonella enteritidis colonization in broiler chickens. Poult. Sci. 90:1441-1448.